T. Rowe Price Associates »

Karyopharm Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $76k 87k 0.87
2023-09-30 $117k 87k 1.34
2023-06-30 $122k 68k 1.79
2023-03-31 $236k 61k 3.90
2022-12-31 $197k 58k 3.40
2022-03-31 $194k 26k 7.38
2021-12-31 $131k 20k 6.42
2021-09-30 $261k 45k 5.81
2021-06-30 $4.1M 399k 10.32
2021-03-31 $5.2M 493k 10.52
2020-12-31 $23M 1.5M 15.48
2020-09-30 $21M 1.4M 14.60
2020-06-30 $37M 2.0M 18.94
2020-03-31 $27M 1.4M 19.21
2019-12-31 $3.3M 170k 19.17
2017-06-30 $126k 14k 9.07
2017-03-31 $178k 14k 12.83
2016-12-31 $130k 14k 9.37
2016-09-30 $135k 14k 9.73
2016-06-30 $93k 14k 6.70
2016-03-31 $124k 14k 8.92
2015-12-31 $184k 14k 13.24